{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13501",
      "entity_text" : "SQSTM1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9UHD2",
      "entity_text" : "TBK1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The fact that Amlx, an inhibitor of TBK1 that blocks mitophagic flux by reducing Optn and p62 / SQSTM1 activities, reduces lysosome size suggests that Amlx may be a potential drug to regulate excess mitophagic flux and maintain lysosomal function under hyperglycemic redox stress.",
  "reading_complete" : "2020-08-04T15:32:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T15:30:38Z",
  "trigger" : "blocks",
  "evidence" : [ "TBK1                            that blocks mitophagic flux by reducing Optn and p62/SQSTM1" ],
  "pmc_id" : "6503994",
  "score" : 0
}